{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T17:26:11Z","timestamp":1785432371845,"version":"3.56.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T00:00:00Z","timestamp":1381449600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s11255-013-0559-z","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T17:07:22Z","timestamp":1381511242000},"page":"433-442","source":"Crossref","is-referenced-by-count":16,"title":["Benefits and harm of niacin and its analog for renal dialysis patients: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"46","author":[{"given":"Yuan-Mei","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Mei","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Hua","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,11]]},"reference":[{"issue":"14","key":"559_CR1","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMra0912522","volume":"362","author":"M Tonelli","year":"2010","unstructured":"Tonelli M, Pannu N, Manns B (2010) Oral phosphate binders in patients with kidney failure. Engl J Med 362(14):1312\u20131324. doi: 10.1056\/NEJMra0912522","journal-title":"Engl J Med"},{"issue":"5","key":"559_CR2","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/ndt\/14.5.1195","volume":"14","author":"K Katai","year":"1999","unstructured":"Katai K, Tanaka H, Tatsumi S, Fukunaga Y, Genjida K, Morita K, Kuboyama N, Suzuki T, Akiba T, Miyamoto K, Takeda E (1999) Nicotinamide inhibits sodium-dependent phosphate cotransport activity in rat small intestine. Nephrol Dial Transplant 14(5):1195\u20131201","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"559_CR3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"GA Block","year":"1998","unstructured":"Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium\u00a0\u00d7\u00a0phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31(4):607\u2013617","journal-title":"Am J Kidney Dis"},{"key":"559_CR4","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1523-1755.2005.09500.x","volume":"95","author":"EA Friedman","year":"2005","unstructured":"Friedman EA (2005) Consequences and management of hyperphosphatemia in patients with renal insufficiency. Kidney Int Suppl 95:S1\u2013S7. doi: 10.1111\/j.1523-1755.2005.09500.x","journal-title":"Kidney Int Suppl"},{"key":"559_CR5","doi-asserted-by":"crossref","unstructured":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) (2009). Kidney Intern Suppl (113):S1\u2013130. doi: 10.1038\/ki.2009.188","DOI":"10.1038\/ki.2009.188"},{"issue":"2","key":"559_CR6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ki.2008.130","volume":"74","author":"KA Hruska","year":"2008","unstructured":"Hruska KA, Mathew S, Lund R, Qiu P, Pratt R (2008) Hyperphosphatemia of chronic kidney disease. Kidney Int 74(2):148\u2013157. doi: 10.1038\/ki.2008.130","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"559_CR7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/ndt\/17.suppl_2.21","volume":"17","author":"HH Malluche","year":"2002","unstructured":"Malluche HH (2002) Aluminium and bone disease in chronic renal failure. Nephrol Dial Transplant 17(Suppl 2):21\u201324","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"559_CR8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11255-007-9300-0","volume":"40","author":"IP Tzanakis","year":"2008","unstructured":"Tzanakis IP, Papadaki AN, Wei M, Kagia S, Spadidakis VV, Kallivretakis NE, Oreopoulos DG (2008) Magnesium carbonate for phosphate control in patients on hemodialysis a randomized controlled trial. Int Urol Nephrol 40(1):193\u2013201. doi: 10.1007\/s11255-007-9300-0","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"559_CR9","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0272-6386(12)80955-3","volume":"19","author":"K Schaefer","year":"1992","unstructured":"Schaefer K, Umlauf E, von Herrath D (1992) Reduced risk of hypercalcemia for hemodialysis patients by administering calcitriol at night. Am J Kidney Dis 19(5):460\u2013464","journal-title":"Am J Kidney Dis"},{"issue":"9288","key":"559_CR10","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0140-6736(01)06299-7","volume":"358","author":"WG Goodman","year":"2001","unstructured":"Goodman WG (2001) Vascular calcification in chronic renal failure. Lancet 358(9288):1115\u20131116. doi: 10.1016\/S0140-6736(01)06299-7","journal-title":"Lancet"},{"issue":"4","key":"559_CR11","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0272-6386(99)70221-0","volume":"33","author":"AJ Bleyer","year":"1999","unstructured":"Bleyer AJ, Burke SK, Dillon M, Garrett B, Kant KS, Lynch D, Rahman SN, Schoenfeld P, Teitelbaum I, Zeig S, Slatopolsky E (1999) A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients. Am J Kidney Dis 33(4):694\u2013701","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"559_CR12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","volume":"62","author":"GM Chertow","year":"2002","unstructured":"Chertow GM, Burke SK, Raggi P (2002) Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62(1):245\u2013252. doi: 10.1046\/j.1523-1755.2002.00434.x","journal-title":"Kidney Int"},{"issue":"1","key":"559_CR13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tibs.2006.11.006","volume":"32","author":"P Belenky","year":"2007","unstructured":"Belenky P, Bogan KL, Brenner C (2007) NAD+\u00a0metabolism in health and disease. Trends Biochem Sci 32(1):12\u201319. doi: 10.1016\/j.tibs.2006.11.006","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"559_CR14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1523-1755.2004.00482.x","volume":"65","author":"Y Takahashi","year":"2004","unstructured":"Takahashi Y, Tanaka A, Nakamura T, Fukuwatari T, Shibata K, Shimada N, Ebihara I, Koide H (2004) Nicotinamide suppresses hyperphosphatemia in hemodialysis patients. Kidney Int 65(3):1099\u20131104. doi: 10.1111\/j.1523-1755.2004.00482.x","journal-title":"Kidney Int"},{"issue":"6","key":"559_CR15","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2215\/CJN.01470307","volume":"2","author":"D Muller","year":"2007","unstructured":"Muller D, Mehling H, Otto B, Bergmann-Lips R, Luft F, Jordan J, Kettritz R (2007) Niacin lowers serum phosphate and increases HDL cholesterol in dialysis patients. Clin J Am Soc Nephrol 2(6):1249\u20131254. doi: 10.2215\/cjn.01470307","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"559_CR16","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s11255-008-9497-6","volume":"41","author":"K Sampathkumar","year":"2009","unstructured":"Sampathkumar K (2009) Niacin and analogs for phosphate control in dialysis\u2014perspective from a developing country. Int Urol Nephrol 41(4):913\u2013918. doi: 10.1007\/s11255-008-9497-6","journal-title":"Int Urol Nephrol"},{"key":"559_CR17","unstructured":"Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The cochrane collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"4","key":"559_CR18","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719\u2013748","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"559_CR19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177\u2013188","journal-title":"Control Clin Trials"},{"issue":"11","key":"559_CR20","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539\u20131558. doi: 10.1002\/sim.1186","journal-title":"Stat Med"},{"issue":"5","key":"559_CR21","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","volume":"273","author":"KF Schulz","year":"1995","unstructured":"Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. J Am Med Assoc 273(5):408\u2013412","journal-title":"J Am Med Assoc"},{"issue":"5","key":"559_CR22","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/089686080902900515","volume":"29","author":"DO Young","year":"2009","unstructured":"Young DO, Cheng SC, Delmez JA, Coyne DW (2009) The effect of oral niacinamide on plasma phosphorus levels in peritoneal dialysis patients. Perit Dial Int 29(5):562\u2013567","journal-title":"Perit Dial Int"},{"issue":"1","key":"559_CR23","first-page":"58","volume":"31","author":"H Shahbazian","year":"2011","unstructured":"Shahbazian H, Zafar Mohtashami A, Ghorbani A, Abbaspour MR, Belladi Musavi SS, Hayati F, Lashkarara GR (2011) Oral nicotinamide reduces serum phosphorus, increases HDL, and induces thrombocytopenia in hemodialysis patients: a double-blind randomized clinical trial. Nefrologia 31(1):58\u201365. doi: 10.3265\/Nefrologia.pre2010 Nov. 10734","journal-title":"Nefrologia"},{"issue":"4","key":"559_CR24","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2215\/CJN.04211007","volume":"3","author":"SC Cheng","year":"2008","unstructured":"Cheng SC, Young DO, Huang Y, Delmez JA, Coyne DW (2008) A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients. Clin J Am Soc Nephrol 3(4):1131\u20131138. doi: 10.2215\/cjn.04211007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"559_CR25","doi-asserted-by":"crossref","first-page":"354","DOI":"10.5301\/jn.5000011","volume":"25","author":"P Aramwit","year":"2012","unstructured":"Aramwit P, Srisawadwong R, Supasyndh O (2012) Effectiveness and safety of extended-release nicotinic acid for reducing serum phosphorus in hemodialysis patients. J Nephrol 25(3):354\u2013362. doi: 10.5301\/jn.5000011","journal-title":"J Nephrol"},{"issue":"3","key":"559_CR26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/0971-4065.98751","volume":"22","author":"M Edalat-Nejad","year":"2012","unstructured":"Edalat-Nejad M, Zameni F, Talaiei A (2012) The effect of niacin on serum phosphorus levels in dialysis patients. Indian J Nephrol 22(3):174\u2013178. doi: 10.4103\/0971-4065.98751","journal-title":"Indian J Nephrol"},{"key":"559_CR27","first-page":"107","volume":"15","author":"J Mallari","year":"2010","unstructured":"Mallari J, Cayabyab S (2010) Niacin and its derivatives lower serum phosphorus level in hemodialysis patients. Nephrology 15:107","journal-title":"Nephrology"},{"issue":"7","key":"559_CR28","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/ndt\/gfh781","volume":"20","author":"N Eto","year":"2005","unstructured":"Eto N, Miyata Y, Ohno H, Yamashita T (2005) Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure. Nephrol Dial Transplant 20(7):1378\u20131384","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"559_CR29","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1172\/JCI110163","volume":"67","author":"SA Kempson","year":"1981","unstructured":"Kempson SA, Colon-Otero G, Ou SY, Turner ST, Dousa TP (1981) Possible role of nicotinamide adenine dinucleotide as an intracellular regulator of renal transport of phosphate in the rat. J Clin Investig 67(5):1347\u20131360","journal-title":"J Clin Investig"},{"issue":"1","key":"559_CR30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1475-2840-12-27","volume":"12","author":"X Tong","year":"2013","unstructured":"Tong X, Peng H, Liu D, Ji L, Niu C, Ren J, Pan B, Hu J, Zheng L, Huang Y (2013) High-density lipoprotein of patients with type 2 diabetes mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate. Cardiovasc Diabetol 12(1):27. doi: 10.1186\/1475-2840-12-27","journal-title":"Cardiovasc Diabetol"},{"issue":"11\u201312","key":"559_CR31","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1111\/j.1582-4934.2008.00472.x","volume":"13","author":"V Petoumenos","year":"2009","unstructured":"Petoumenos V, Nickenig G, Werner N (2009) High-density lipoprotein exerts vasculoprotection via endothelial progenitor cells. J Cell Mol Med 13(11\u201312):4623\u20134635. doi: 10.1111\/j.1582-4934.2008.00472.x","journal-title":"J Cell Mol Med"},{"issue":"11","key":"559_CR32","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1161\/ATVBAHA.112.300135","volume":"32","author":"MG Sorci-Thomas","year":"2012","unstructured":"Sorci-Thomas MG, Thomas MJ (2012) High density lipoprotein biogenesis, cholesterol efflux, and immune cell function. Arterioscler Thromb Vasc Biol 32(11):2561\u20132565","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"559_CR33","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jacc.2012.10.030","volume":"61","author":"PM Lavigne","year":"2013","unstructured":"Lavigne PM, Karas RH (2013) The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression. J Am Coll Cardiol 61(4):440\u2013446. doi: 10.1016\/j.jacc.2012.10.030","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"559_CR34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2796.2005.01528.x","volume":"258","author":"LA Carlson","year":"2005","unstructured":"Carlson LA (2005) Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review. J Intern Med 258(2):94\u2013114. doi: 10.1111\/j.1365-2796.2005.01528.x","journal-title":"J Intern Med"},{"key":"559_CR35","doi-asserted-by":"crossref","unstructured":"Pieper JA (2003) Overview of niacin formulations: differences in pharmacokinetics, efficacy, and safety. Am J Health Syst Pharm 60 (13 Suppl 2):S9\u201314; quiz S25","DOI":"10.1093\/ajhp\/60.suppl_2.S9"},{"issue":"6","key":"559_CR36","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jacl.2010.08.020","volume":"4","author":"HE Bays","year":"2010","unstructured":"Bays HE, Shah A, Lin J, McCrary Sisk C, Paolini JF, Maccubbin D (2010) Efficacy and tolerability of extended-release niacin\/laropiprant in dyslipidemic patients with metabolic syndrome. J Clin Lipidol 4(6):515\u2013521. doi: 10.1016\/j.jacl.2010.08.020","journal-title":"J Clin Lipidol"},{"issue":"6","key":"559_CR37","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.amjcard.2012.05.009","volume":"110","author":"DL Maccubbin","year":"2012","unstructured":"Maccubbin DL, Chen F, Anderson JW, Sirah W, McCrary Sisk C, Kher U, Olsson AG, Bays HE, Mitchel YB (2012) Effectiveness and safety of laropiprant on niacin-induced flushing. Am J Cardiol 110(6):817\u2013822. doi: 10.1016\/j.amjcard.2012.05.009","journal-title":"Am J Cardiol"},{"key":"559_CR38","doi-asserted-by":"crossref","unstructured":"McKenney J, Bays H, Koren M, Ballantyne CM, Paolini JF, Mitchel Y, Betteridge A, Kuznetsova O, Sapre A, Sisk CM, Maccubbin D (2010) Safety of extended-release niacin\/laropiprant in patients with dyslipidemia. J Clin Lipidol 4 (2):105-112 e101. doi: 10.1016\/j.jacl.2010.02.002","DOI":"10.1016\/j.jacl.2010.02.002"},{"issue":"5","key":"559_CR39","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0025-6196(12)60393-0","volume":"67","author":"T O\u2019Brien","year":"1992","unstructured":"O\u2019Brien T, Silverberg JD, Nguyen TT (1992) Nicotinic acid-induced toxicity associated with cytopenia and decreased levels of thyroxine-binding globulin. Mayo Clinic Proc 67(5):465\u2013468","journal-title":"Mayo Clinic Proc"},{"issue":"11","key":"559_CR40","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0895-4356(00)00242-0","volume":"53","author":"JA Sterne","year":"2000","unstructured":"Sterne JA, Gavaghan D, Egger M (2000) Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 53(11):1119\u20131129","journal-title":"J Clin Epidemiol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-013-0559-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-013-0559-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-013-0559-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T18:44:00Z","timestamp":1596653040000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-013-0559-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,11]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["559"],"URL":"https:\/\/doi.org\/10.1007\/s11255-013-0559-z","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,11]]}}}